Our Recent Coverage on COVID-19

We present the week's summaries, commentary, and news on the pandemic.

Dear readers,

This week, NEJM Journal Watch covered COVID-19–related topics including new data on antiviral drugs, myocardial injury associated with COVID-19, SARS-CoV-2 antibody levels, and the effect of blood group on disease outcomes; we also covered updated guidelines on management and treatment of COVID-19.

This information appears on the NEJM Journal Watch COVID-19 page (https://www.jwatch.org/covid-19) and on the New England Journal of Medicine coronavirus site (https://www.nejm.org/coronavirus).

As always, we continue to provide our regular coverage of other important infectious diseases research.

Author

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Richard T. Ellison III, MD

Disclosures

Consult/Advisory BoardAcurx Pharmaceuticals, LLC;

Grant/Research SupportDoctors Company Foundation, Massachusetts Department of Public Health

Our Recent Coverage on COVID-19

Topics

Author